Start
Completion

Psychedelic Therapy for Wellness Studies Retrospectively

Active not yet recruitingRegisteredCTG

This observational cohort study (n=100) aims to assess the efficacy of psychedelics, including psilocybin, MDMA, LSD, and ketamine, for improving measures of wellness.

Details

This retrospective cohort study will measure self-reported treatment effects of psychedelics on a composite wellness score combining patient global impression, mood, pain, function and disability measures.

Approximately 50 non-active military participants will be recruited via advertising to self-identify past therapeutic psychedelic use; data collection is a single survey including PGIC, PEG, HADS, DI and adverse-event history.

Topics:Public Health, Prevention & Behaviour Change

Registry

Registry linkNCT05469243